These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 9704879)

  • 1. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
    Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
    Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
    Wang JQ; McGinty JF
    J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day/night differences in D1 but not D2 DA receptor protection from EEDQ denaturation in rats treated with continuous cocaine.
    Burger LY; Martin-Iverson MT
    Synapse; 1993 Jan; 13(1):20-9. PubMed ID: 8093985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptors.
    Coirini H; Källström L; Wiesel FA; Johnson AE
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):197-210. PubMed ID: 9387879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of the locomotor-sensitizing effects of the D2 dopamine agonist bromocriptine by either the D1 antagonist SCH 23390 or the D2 antagonist raclopride.
    Wise RA; Carlezon WA
    Synapse; 1994 Jul; 17(3):155-9. PubMed ID: 7974197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
    Mela F; Marti M; Bido S; Cenci MA; Morari M
    Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM; Wooten GF; Trugman JM
    J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ; Marshall JF
    Synapse; 2000 Jun; 36(3):194-204. PubMed ID: 10819899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.
    Yu J; Källström L; Wiesel FA; Johnson AE
    Synapse; 1999 Dec; 34(3):192-207. PubMed ID: 10523757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptics differentially modulate central dopamine D1-receptor binding.
    Johnson AE; Coirini H; Källström L; Gunne LM; Wiesel FA
    Neuroreport; 1995 Apr; 6(6):933-6. PubMed ID: 7612886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
    Iorio LC; Cohen M; Coffin VL
    J Pharmacol Exp Ther; 1991 Jul; 258(1):118-23. PubMed ID: 1830098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography.
    Altar CA; Marien MR
    J Neurosci; 1987 Jan; 7(1):213-22. PubMed ID: 2949066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurokinin1 receptor antagonist CP-99,994 reduces catalepsy produced by the dopamine D2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum.
    Anderson JJ; Randall S; Chase TN
    J Pharmacol Exp Ther; 1995 Aug; 274(2):928-36. PubMed ID: 7636756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.
    Xu ZC; Ling G; Sahr RN; Neal-Beliveau BS
    Brain Res; 2005 Mar; 1038(2):163-70. PubMed ID: 15757632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study.
    Rao PA; Molinoff PB; Joyce JN
    Brain Res Dev Brain Res; 1991 Jun; 60(2):161-77. PubMed ID: 1832594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right-left asymmetry of D1- and D2-receptor density is lost in the basal ganglia of old rats.
    Giardino L
    Brain Res; 1996 May; 720(1-2):235-8. PubMed ID: 8782918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific involvement of striatal D1 and D2 dopamine receptors in the neuroleptic catalepsy in rats.
    Wardas J; Pietraszek M; Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(4):349-53. PubMed ID: 8616516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: an autoradiographic study.
    Morissette M; Lévesque D; Di Paolo T
    Mol Pharmacol; 1992 Sep; 42(3):480-8. PubMed ID: 1357544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra.
    Hemsley KM; Crocker AD
    Neuropsychopharmacology; 2001 Oct; 25(4):514-26. PubMed ID: 11557165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.